Glaukos Corporation (GKOS) is a publicly traded Healthcare sector company. As of November 11, 2026, GKOS trades at $242.98 with a market cap of $14.13B and a P/E ratio of -48.68. GKOS moved -1.07% today. Year to date, GKOS is +113.41%; over the trailing twelve months it is +167.45%. Its 52-week range spans $73.16 to $255.19. Analyst consensus is strong buy with an average price target of $237.82. Rallies surfaces GKOS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
11 analysts cover GKOS: 0 strong buy, 10 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $237.82.
| Metric | Value |
|---|---|
| Price | $242.98 |
| Market Cap | $14.13B |
| P/E Ratio | -48.68 |
| EPS | $-3.26 |
| Dividend Yield | 0.00% |
| 52-Week High | $255.19 |
| 52-Week Low | $73.16 |
| Volume | 599.93K |
| Avg Volume | 0 |
| Revenue (TTM) | $612.84M |
| Net Income | $-188.05M |
| Gross Margin | 60.70% |
11 analysts cover GKOS: 0 strong buy, 10 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $237.82.